Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025 475.5% Revenue growth, 20253 Where the money goes Where each dollar of revenue went, fiscal 2025 Cost of revenue Research and development
Cost of revenue 62¢ $20.4M Research and development 37¢ $12.4M Income tax 1¢ $282.0K Out of $23.8M in revenue.3 The company lost money this year.
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue4 5 3 $23.8M in 20250 $10.0M $20.0M $30.0M 2022: $0 $0 2022 2023: $433.0K $433.0K 2023 2024: $4.1M $4.1M 2024 +857% 2025: $23.8M $23.8M 2025 +476% Gross profit4 5 3 $3.4M in 20250 $1.0M $2.0M $3.0M $4.0M 2022: $0 $0 2022 2023: $139.0K $139.0K 2023 2024: $1.6M $1.6M 2024 +1051% 2025: $3.4M $3.4M 2025 +113% Operating income4 5 3 -$59.9M in 2025+1075% since 2022 -$60.0M -$40.0M -$20.0M 0 2022: -$5.1M -$5.1M 2022 2023: -$16.0M -$16.0M 2023 +215% 2024: -$26.4M -$26.4M 2024 +64% 2025: -$59.9M -$59.9M 2025 +127% Net income4 5 3 -$159.8M in 2025+3132% since 2022 -$200.0M -$150.0M -$100.0M -$50.0M 0 2022: -$4.9M -$4.9M 2022 2023: -$16.3M -$16.3M 2023 +229% 2024: -$32.4M -$32.4M 2024 +99% 2025: -$159.8M -$159.8M 2025 +393%
Revenue6 7 $5.1M in Q2 FY2026+23% since Q1 FY2026 0 $2.0M $4.0M $6.0M Q1 FY2026: $4.2M $4.2M Q1 FY2026 Q2 FY2026: $5.1M $5.1M Q2 FY2026 +23% Gross profit6 7 $1.5M in Q2 FY2026−11% since Q1 FY2026 0 $500.0K $1.0M $1.5M $2.0M Q1 FY2026: $1.7M $1.7M Q1 FY2026 Q2 FY2026: $1.5M $1.5M Q2 FY2026 −11% Operating income6 7 -$34.2M in Q2 FY2026+37% since Q1 FY2026 -$40.0M -$30.0M -$20.0M -$10.0M 0 Q1 FY2026: -$24.9M -$24.9M Q1 FY2026 Q2 FY2026: -$34.2M -$34.2M Q2 FY2026 +37% Net income6 7 -$34.0M in Q2 FY2026+377% since Q1 FY2026 -$40.0M -$30.0M -$20.0M -$10.0M 0 Q1 FY2026: -$7.1M -$7.1M Q1 FY2026 Q2 FY2026: -$34.0M -$34.0M Q2 FY2026 +377%
Fiscal year 2021 2022 2023 2024 2025 Revenue $04 $433.0K5 $4.1M3 $23.8M3 Cost of revenue $04 $294.1K5 $2.5M3 $20.4M3 Gross profit $04 $139.0K5 $1.6M3 $3.4M3 Research and development $1.3M4 $764.6K5 $3.1M3 $12.4M3 Operating income -$5.1M4 -$16.0M5 -$26.4M3 -$59.9M3 Interest $04 $118.5K4 Income tax $04 -$6.1K5 $111.0K3 $282.0K3 Net income -$4.9M4 -$16.3M5 -$32.4M3 -$159.8M3 Earnings per share -$0.188 -$0.495 -$0.633 -$2.113 Earnings per share (diluted) -$0.495 -$0.633 -$2.113
Total assets8 4 5 3 $498.0M in 2025+6872% since 2021 0 $200.0M $400.0M $600.0M 2021: $7.1M $7.1M 2021 2022: $12.5M $12.5M 2022 +75% 2023: $27.5M $27.5M 2023 +120% 2024: $94.3M $94.3M 2024 +243% 2025: $498.0M $498.0M 2025 +428% Total liabilities8 4 5 3 $235.1M in 2025+20435% since 2021 0 $100.0M $200.0M $300.0M 2021: $1.1M $1.1M 2021 2022: $2.7M $2.7M 2022 +134% 2023: $8.7M $8.7M 2023 +225% 2024: $43.2M $43.2M 2024 +396% 2025: $235.1M $235.1M 2025 +445% Shareholders’ equity8 4 5 3 $204.2M in 2025+3304% since 2021 0 $100.0M $200.0M $300.0M 2021: $6.0M $6.0M 2021 2022: $9.8M $9.8M 2022 +64% 2023: $16.3M $16.3M 2023 +66% 2024: $47.9M $47.9M 2024 +194% 2025: $204.2M $204.2M 2025 +326% Cash4 5 3 $285.6M in 2025+9569% since 2021 0 $100.0M $200.0M $300.0M 2021: $3.0M $3.0M 2021 2022: $2.4M $2.4M 2022 −19% 2023: $7.9M $7.9M 2023 +231% 2024: $61.9M $61.9M 2024 +683% 2025: $285.6M $285.6M 2025 +361% Long-term debt3 $1.5M in 2025+2% since 2024 0 $500.0K $1.0M $1.5M 2024: $1.4M $1.4M 2024 2025: $1.5M $1.5M 2025 +2%
Total assets6 7 $572.0M in Q2 FY2026+15% since Q1 FY2025 0 $200.0M $400.0M $600.0M Q1 FY2025: $498.0M $498.0M Q1 FY2025 Q2 FY2025: $498.0M $498.0M Q2 FY2025 +0% Q1 FY2026: $587.7M $587.7M Q1 FY2026 +18% Q2 FY2026: $572.0M $572.0M Q2 FY2026 −3% Total liabilities6 7 $297.3M in Q2 FY2026+26% since Q1 FY2025 0 $100.0M $200.0M $300.0M Q1 FY2025: $235.1M $235.1M Q1 FY2025 Q2 FY2025: $235.1M $235.1M Q2 FY2025 +0% Q1 FY2026: $288.7M $288.7M Q1 FY2026 +23% Q2 FY2026: $297.3M $297.3M Q2 FY2026 +3% Shareholders’ equity6 7 $264.7M in Q2 FY2026+30% since Q1 FY2025 0 $100.0M $200.0M $300.0M Q1 FY2025: $204.2M $204.2M Q1 FY2025 Q2 FY2025: $204.2M $204.2M Q2 FY2025 +0% Q1 FY2026: $289.0M $289.0M Q1 FY2026 +42% Q2 FY2026: $299.0M $299.0M Q2 FY2026 +3% Q2 FY2026: $264.7M $264.7M Q2 FY2026 −11% Cash6 7 $219.6M in Q2 FY2026−21% since Q1 FY2025 0 $100.0M $200.0M $300.0M Q1 FY2025: $279.6M $279.6M Q1 FY2025 Q2 FY2025: $279.6M $279.6M Q2 FY2025 +0% Q1 FY2026: $207.3M $207.3M Q1 FY2026 −26% Q2 FY2026: $219.6M $219.6M Q2 FY2026 +6% Long-term debt6 7 $5.3M in Q2 FY2026+257% since Q1 FY2025 0 $2.0M $4.0M $6.0M Q1 FY2025: $1.5M $1.5M Q1 FY2025 Q2 FY2025: $1.5M $1.5M Q2 FY2025 +0% Q1 FY2026: $5.1M $5.1M Q1 FY2026 +244% Q2 FY2026: $5.3M $5.3M Q2 FY2026 +4%
Fiscal year 2021 2022 2023 2024 2025 Cash $3.0M4 $2.4M5 $7.9M3 $61.9M5 $285.6M3 Current assets $3.2M8 $3.3M4 $10.5M5 $65.7M3 $399.9M3 Total assets $7.1M8 $12.5M4 $27.5M5 $94.3M3 $498.0M3 Current liabilities $303.4K8 $1.9M4 $5.7M5 $7.1M3 $32.7M3 Long-term debt $1.4M3 $1.5M3 Total liabilities $1.1M8 $2.7M4 $8.7M5 $43.2M3 $235.1M3 Shareholders’ equity $6.0M8 $9.8M4 $16.3M5 $47.9M3 $204.2M3 Shares outstanding 20.7M shares8 35.9M shares4 48.9M shares5 72.1M shares3 111.7M shares3
Cash from operations4 5 3 -$37.8M in 2025+1185% since 2022 -$40.0M -$30.0M -$20.0M -$10.0M 0 2022: -$2.9M -$2.9M 2022 2023: -$5.4M -$5.4M 2023 +84% 2024: -$16.7M -$16.7M 2024 +208% 2025: -$37.8M -$37.8M 2025 +126% Capital spending4 5 3 $9.7M in 2025+116% since 2022 0 $2.5M $5.0M $7.5M $10.0M 2022: $4.5M $4.5M 2022 2023: $2.3M $2.3M 2023 −48% 2024: $9.7M $9.7M 2024 +315% 2025: $9.7M $9.7M 2025 −0% Free cash flow4 5 3 -$47.4M in 2025+540% since 2022 -$60.0M -$40.0M -$20.0M 0 2022: -$7.4M -$7.4M 2022 2023: -$7.7M -$7.7M 2023 +4% 2024: -$26.4M -$26.4M 2024 +241% 2025: -$47.4M -$47.4M 2025 +80% Dividends paid5 3 $0 in 20250 $1.0M $2.0M $3.0M 2023: $0 $0 2023 2024: $2.8M $2.8M 2024 2025: $0 $0 2025
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2021 2022 2023 2024 2025 Cash from operations -$2.9M4 -$5.4M5 -$16.7M3 -$37.8M3 Capital spending $4.5M4 $2.3M5 $9.7M3 $9.7M3 Free cash flow -$7.4M -$7.7M -$26.4M -$47.4M Dividends paid $05 $2.8M3 $03
Compare ASP Isotopes Inc. with another company
Recent filings
Oct 14, 2026 144 Oct 8, 2026 SCHEDULE 13D Oct 8, 2026 3 Oct 2, 2026 8-K Oct 1, 2026 4 Sep 30, 2026 4 Sep 25, 2026 144 Sep 10, 2026 4 Sep 9, 2026 425 Sep 9, 2026 425 Sep 8, 2026 8-K Sep 4, 2026 4 Sep 4, 2026 4 Sep 4, 2026 4 Sep 2, 2026 144
Every filing from the last three years, summarized . The full record is on SEC EDGAR.1